CAR T Cells: Keeping Pace With Adverse Effects of an Emerging Therapy – Oncology Nurse Advisor
Oncology Nurse Advisor |
CAR T Cells: Keeping Pace With Adverse Effects of an Emerging Therapy
Oncology Nurse Advisor DENVER,CO — The oncology nurses’ role in monitoring and early recognition of the signs and symptoms of chimeric antigen receptor T cell (CAR T-cell) toxicities is significant considering the potential severity of these adverse effects, according to a … |
|
Researchers design process to better understand how advanced melanoma adapts to immunotherapy
Science Daily The findings lay the groundwork for developing new and improved combination therapies for patients who are resistant to stand-alone immunotherapy treatments. Pembrolizumab (marketed as Keytruda) works by signaling the patient’s immune system to … |